<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05058469</url>
  </required_header>
  <id_info>
    <org_study_id>PDT and (D)APT</org_study_id>
    <nct_id>NCT05058469</nct_id>
  </id_info>
  <brief_title>Tracheotomy With and Without Dual Antiplatelet Therapy</brief_title>
  <acronym>PDT and (D)APT</acronym>
  <official_title>Evaluation of the Safety of Percutaneous Tracheotomies in Intensive Care Patients With and Without Antiplatelet Therapy and Comparison of Two Tracheotomy Techniques</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Asklepios Neurological Clinic Bad Salzhausen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Asklepios Neurological Clinic Bad Salzhausen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Platelet-inhibiting drugs are often used after vascular interventions. Patients who require&#xD;
      such therapies are often critically ill, are treated in intensive care units and often&#xD;
      require long-term ventilation. For long-term ventilation a tracheotomy is necessary, which is&#xD;
      usually performed as a percutaneous dilatative tracheotomy (PDT). As part of this&#xD;
      intervention, there is (theoretically) an increased risk of bleeding/an increased rate of&#xD;
      complications in patients with a antiplatelet therapy. In addition, there are various&#xD;
      techniques for performing a PDT.&#xD;
&#xD;
      The current study aims to investigate the frequency of bleeding/complications taking into&#xD;
      account the technique used in PDT.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2021</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">June 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Measurement of bleeding during Percutaneous Dilational Tracheostomy (PDT) with and without antiplatelet therapy (AP).</measure>
    <time_frame>3 days</time_frame>
    <description>bleeding (yes/no)&#xD;
intervention (yes/no)&#xD;
decrease (&gt;= 1 g/dl) of hemoglobin (yes/no)&#xD;
number of blood transfusion(s)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>- Does the technique of PDT affect the bleeding rate? - How often are recognizable cartilage pin fractures in the context of a PDT? - Influence of AP and PDT technology on the frequency of need for a blood transfusion?</measure>
    <time_frame>14 days</time_frame>
    <description>cartilage pin fractures seen in endoscopy</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Tracheostomy Hemorrhage</condition>
  <arm_group>
    <arm_group_label>Tracheotomy without antiplatelet therapy+technique 1</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Tracheotomy under antiplatelet therapy+technique 1</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Tracheotomy without antiplatelet therapy+technique 2</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Tracheotomy under antiplatelet therapy+technique 2</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Tracheotomy</intervention_name>
    <description>Tracheotomy in patients +/- antiplatelet therapy</description>
    <arm_group_label>Tracheotomy under antiplatelet therapy+technique 1</arm_group_label>
    <arm_group_label>Tracheotomy under antiplatelet therapy+technique 2</arm_group_label>
    <arm_group_label>Tracheotomy without antiplatelet therapy+technique 1</arm_group_label>
    <arm_group_label>Tracheotomy without antiplatelet therapy+technique 2</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who underwent Percutaneous Dilational Tracheostomy within the last 5 years.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients who underwent Percutaneous Dilational Tracheostomy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  none&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Dirk Bandorski, MD</last_name>
    <phone>+496043804212</phone>
    <email>d.bandorski@asklepios.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Neurologische Klinik Bad Salzhausen</name>
      <address>
        <city>Nidda</city>
        <zip>63667</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 14, 2021</study_first_submitted>
  <study_first_submitted_qc>September 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 27, 2021</study_first_posted>
  <last_update_submitted>October 4, 2021</last_update_submitted>
  <last_update_submitted_qc>October 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

